Aurora Cannabis is a licensed cannabis producer serving both the consumer and medical marijuana markets.
In its fourth-quarter financial results for 2021, Aurora Cannabis reported net revenue of $35 million in its Medical Cannabis division, which is a 9% increase from the same quarter of 2020.
The increase was due to an overall decrease in production costs after the company closed down non-core facilities as a part of its business transformation plan.
However, net revenue showed an 8% improvement from the third quarter of 2021.
Aurora Cannabis operates in a rapidly growing industry that faces significant regulatory uncertainty.
Nothing in the article constitutes legal, professional, investment and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein.